European Journal of Cancer, 1879-0852

Journal

More filtering options
  1. 1994
  2. Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group

    Mårten Fernö, Bo Baldetorp, Åke Borg, Brouillet, J. P., Håkan Olsson, Rochefort, H., Sellberg, G., Sigurdsson, H. & Dick Killander, 1994, In : European Journal of Cancer. 30a, 14, p. 2042-2048

    Research output: Contribution to journalArticle

  3. Hypersomy of chromosome 15 with retrovirally rearranged c-myc, loss of germline c-myc and IgK/c-myc juxtaposition in a macrophage-monocytic tumour line

    Imreh, S., Wang, Y., Panda, C. K., Babonits, M., H Axelson, Silva, S., Szeles, A., Wiener, F. & Klein, G., 1994, In : European Journal of Cancer. 30A, 7, p. 994-1002 9 p.

    Research output: Contribution to journalArticle

  4. At what age do sunburn episodes play a crucial role for the development of malignant melanoma

    Westerdahl, J., H. Olsson & C. Ingvar, 1994 Jan 1, In : European Journal of Cancer. 30, 11, p. 1647-1654 8 p.

    Research output: Contribution to journalArticle

  5. 1995
  6. A Phase I/II Evaluation of Metoclopramide as a Radiosensitiser in Patients with Inoperable Squamous Cell Carcinoma of the Lung

    Kjellén, E., Pero, R., Eva Brun, Ewers, S-B., Olof Jarlman, Tommy Knöös, Per Malmström, Jan Tennvall, Dick Killander, Olsson, A., Sheng, Y. & Johan Wennerberg, 1995, In : European Journal of Cancer. 31, 13-14, p. 2196-2202

    Research output: Contribution to journalArticle

  7. Effects of intrapleural mitoxantrone and mepacrine on malignant pleural effusion--a randomised study

    Leif Bjermer, Gruber, A., Sue-Chu, M., Sandström, T., Eksborg, S. & Henriksson, R., 1995, In : European Journal of Cancer. 31, 13-14, p. 2203-2208

    Research output: Contribution to journalArticle

  8. The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas

    H Axelson, Henriksson, M., Wang, Y., Magnusson, K. P. & Klein, G., 1995 Nov, In : European Journal of Cancer. 31A, 12, p. 2099-104 6 p.

    Research output: Contribution to journalArticle

  9. 1996
  10. 1997
  11. Tumor Biological Features of BRCA1-Induced Breast Cancer

    Johannsson, O. T., Idvall, I., Andersson, C., Åke Borg, Barkardóttir, R. B., Egilsson, V. & Håkan Olsson, 1997, In : European Journal of Cancer. 33, 3, p. 362-371

    Research output: Contribution to journalArticle

  12. Tumour biological features of BRCA1-induced breast and ovarian cancer

    Jóhannsson, O. T., Idvall, I., Anderson, C., Åke Borg, Barkardóttir, R. B., Egilsson, V. & Håkan Olsson, 1997 Mar, In : European Journal of Cancer. 33, 3, p. 362-371

    Research output: Contribution to journalArticle

  13. 1998
  14. BRCA1-positive patients are small for gestational age compared with their unaffected relatives

    H Jernström, Johannsson, O., A Borg, Ivarsson, H. & H Olsson, 1998 Feb, In : European Journal of Cancer. 34, 3, p. 368-71

    Research output: Contribution to journalArticle

  15. 1999
  16. Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers

    Johannsson, O., Niklas Loman, Möller, T., Ulf Kristoffersson, Åke Borg & Håkan Olsson, 1999, In : European Journal of Cancer. 35, 8, p. 1248-1257

    Research output: Contribution to journalArticle

  17. Perivascular cell protection in vivo and increased cell survival in vitro by the antihypertensive agent carvedilol following radiation

    Jonsson, O. E., Leif Bjermer, Denekamp, J., Grankvist, K. & Henriksson, R., 1999, In : European Journal of Cancer. 35, 8, p. 1268-1273

    Research output: Contribution to journalArticle

  18. Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study

    O Bratt, U Kristoffersson, Lundgren, R. & Håkan Olsson, 1999 Feb, In : European Journal of Cancer. 35, 2, p. 272-7 6 p.

    Research output: Contribution to journalArticle

  19. 2000
  20. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients

    Bjordal, K., de Graeff, A., Fayers, P. M., Hammerlid, E., van Pottelsberghe, C., Curran, D., Ahlner-Elmqvist, M., Maher, E. J., Meyza, J. W., Bredart, A., Soderholm, A. L., Arraras, J. J., Feine, J. S., Abendstein, H., Morton, R. P., Pignon, T., Huguenin, P., Bottomly, A. & Kaasa, S., 2000, In : European Journal of Cancer. 36, 14, p. 1796-1807

    Research output: Contribution to journalArticle

  21. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol

    Elomaa, I., Blomqvist, C. P., Saeter, G., Akerman, M., Stenwig, E., Thomas Wiebe, Bjork, O. & Thor Alvegård, 2000, In : European Journal of Cancer. 36, 7, p. 875-880

    Research output: Contribution to journalArticle

  22. Prognosis and clinical presentation of BRCA2-associated breast cancer

    Niklas Loman, Johannsson, O., Pär-Ola Bendahl, Dahl, N., Einbeigi, Z., Gerdes, A., Åke Borg & Håkan Olsson, 2000, In : European Journal of Cancer. 36, 11, p. 1365-1373

    Research output: Contribution to journalArticle

  23. Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer

    Jönsson, M., Borg, A., M Nilbert & Andersson, T., 2000 Jan, In : European Journal of Cancer. 36, 2, p. 242-8 7 p.

    Research output: Contribution to journalArticle

  24. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer

    O Bratt, Damber, J. E., Emanuelsson, M., U Kristoffersson, Lundgren, R., Håkan Olsson & Grönberg, H., 2000 Jan, In : European Journal of Cancer. 36, 2, p. 235-241

    Research output: Contribution to journalArticle

  25. 2001
  26. Genetic epidemiology of BRCA1 mutations in Norway

    Moller, P., Heimdal, K., Apold, J., Fredriksen, A., Åke Borg, Hovig, E., Hagen, A., Hagen, B., Pedersen, J. C. & Maehle, L., 2001, In : European Journal of Cancer. 37, 18, p. 2428-2434

    Research output: Contribution to journalArticle

  27. Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients

    Fernebro, E., Madsen, R. R., Mårten Fernö, Brunner, N., Pär-Ola Bendahl, Christensen, I. J., Johnson, A. & Mef Nilbert, 2001, In : European Journal of Cancer. 37, 4, p. 486-491

    Research output: Contribution to journalArticle

  28. Survival of children with liver tumours in Europe 1978--1989

    Möller, T., Garwicz, S., Corazziari, I. & Magnani, C., 2001, In : European Journal of Cancer. 37, 6, p. 744-749

    Research output: Contribution to journalArticle

  29. The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series

    Möller, P., Åke Borg, Heimdal, K., Apold, J., Johan Vallon-Christersson, Hovig, E. & Maehle, L., 2001, In : European Journal of Cancer. 37, 8, p. 1027-1032

    Research output: Contribution to journalArticle

  30. Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer

    Fredstorp-Lidebring, M., Pär-Ola Bendahl, Brunner, N., Casslén, B., Thomas Högberg, Långström-Einarsson, E., Willén, R. & Mårten Fernö, 2001, In : European Journal of Cancer. 37, 18, p. 2339-2348

    Research output: Contribution to journalArticle

  31. A hypothesis about tumour development and the clinical features of hereditary breast cancers

    H Olsson, 2001 Nov, In : European Journal of Cancer. 37, 16, p. 2023-2029

    Research output: Contribution to journalArticle

  32. 2002
  33. C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer

    Sjostrom, J., Collan, J., von Boguslawski, K., Franssila, K., Bengtsson, NO., Mjaaland, I., Per Malmström, Ostenstad, B., Wist, E., Valvere, V., Bergh, J., Skiold-Petterson, D., Saksela, E. & Blomqvist, C., 2002, In : European Journal of Cancer. 38, 4, p. 535-542

    Research output: Contribution to journalArticle

  34. Comment on "The frequency of breast cancer screening: results from the UKCCCR Randomised Trial"

    Ingvar Andersson, 2002, In : European Journal of Cancer. 38, 11, p. 1427-1428

    Research output: Contribution to journalDebate/Note/Editorial

  35. Cancer risks in Nordic immigrants and their offspring in Sweden

    K Hemminki & Xinjun Li, 2002 Dec, In : European Journal of Cancer. 38, 18, p. 2428-34 7 p.

    Research output: Contribution to journalArticle

  36. 2003
  37. An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozole

    Carsten Rose, Vtoraya, O., Pluzanska, A., Davidson, N., Gershanovich, M., Thomas, R., Johnson, S., Caicedo, JJ., Gervasio, H., Manikhas, G., Ben Ayed, F., Burdette-Radoux, S., Chaudri-Ross, HA. & Lang, R., 2003, In : European Journal of Cancer. 39, 16, p. 2318-2327

    Research output: Contribution to journalArticle

  38. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening.

    Per Malmström, Holmberg, L., Anderson, H., Mattsson, J., Jönsson, P. E., Tennvall-Nittby, L., Balldin, G., Lovén, L., Svensson, J. H., Christian Ingvar, Möller, T., Holmberg, E. & Wallgren, A., 2003, In : European Journal of Cancer. 39, 12, p. 1690-1697

    Research output: Contribution to journalArticle

  39. Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis-the SIN-system.

    Pelle Gustafson, Åkerman, M., Thor Alvegård, Coindre, J-M., Fletcher, C. D. M., Anders Rydholm & Willén, H., 2003, In : European Journal of Cancer. 39, 11, p. 1568-1576

    Research output: Contribution to journalArticle

  40. Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer

    Luoma, ML., Hakamies-Blomqvist, L., Sjostrom, J., Pluzanska, A., Ottoson, S., Mouridsen, H., Bengtsson, NO., Bergh, J., Per Malmström, Valvere, V., Tennvall, L. & Blomqvist, C., 2003, In : European Journal of Cancer. 39, 10, p. 1370-1376

    Research output: Contribution to journalArticle

  41. Radiation dose as a risk factor for malignant melanoma following childhood cancer

    Guerin, S., Dupuy, A., Anderson, H., Shamsaldin, A., Svahn-Tapper, G., Moller, T., Quiniou, E., Garwicz, S., Hawkins, M., Avril, MF., Oberlin, O., Chavaudra, J. & de Vathaire, F., 2003, In : European Journal of Cancer. 39, 16, p. 2379-2386

    Research output: Contribution to journalArticle

  42. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders

    Smeland, S., Muller, C., Thor Alvegård, Wiklund, T., Thomas Wiebe, Bjork, O., Stenwig, AE., Willen, H., Holmstrom, T., Folleras, G., Brosjo, O., Kivioja, A., Jonsson, K., Monge, O. & Saeter, G., 2003, In : European Journal of Cancer. 39, 4, p. 488-494

    Research output: Contribution to journalArticle

  43. Defective mismatch-repair in patients with multiple primary tumours including colorectal cancer

    Ericson, K., Halvarsson, B., Nagel, J., Rambech, E., M Planck, Piotrowska, Z., Olsson, H. & M Nilbert, 2003 Jan, In : European Journal of Cancer. 39, 2, p. 240-8 9 p.

    Research output: Contribution to journalArticle

  44. 2004
  45. An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6

    Steiner, H., Berger, AP., Godoy-Tundidor, S., Anders Bjartell, Hans Lilja, Bartsch, G., Hobisch, A. & Culig, Z., 2004, In : European Journal of Cancer. 40, 7, p. 1066-1072

    Research output: Contribution to journalArticle

  46. Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival: a validation study

    Holten-Andersen, M., Christensen, IJ., Mef Nilbert, Pär-Ola Bendahl, Nielsen, HJ., Brunner, N. & Fernebro, E., 2004, In : European Journal of Cancer. 40, 1, p. 64-72

    Research output: Contribution to journalArticle

  47. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables? - A population-based study

    Christensen, LH., Engholm, G., Ceberg, J., Hein, S., Perfekt, R., Tange, UB., Andersson, M., Mouridsen, HT., Möller, T. & Storm, HH., 2004, In : European Journal of Cancer. 40, 8, p. 1233-1243

    Research output: Contribution to journalArticle

  48. Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri

    Luostarinen, T., Lehtinen, M., Bjorge, T., Abeler, V., Hakama, M., Hallmans, G., Jellum, E., Koskela, P., Lenner, P., Lie, AK., Paavonen, J., Pukkala, E., Saikku, P., Sigstad, E., Thoresen, S., Youngman, LD., Dillner, J. & Hakulinen, T., 2004, In : European Journal of Cancer. 40, 7, p. 1058-1065

    Research output: Contribution to journalArticle

  49. Letter to the editor

    Carsten Rose, 2004, In : European Journal of Cancer. 40, 18, p. 2859-2859

    Research output: Contribution to journalLetter

  50. Association of brain tumours with other neoplasms in families

    K Hemminki & Xinjun Li, 2004 Jan, In : European Journal of Cancer. 40, 2, p. 253-9 7 p.

    Research output: Contribution to journalArticle

  51. One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden

    Malander, S., Ridderheim, M., Måsbäck, A., N Loman, U Kristoffersson, Håkan Olsson, M Nilbert & Åke Borg, 2004 Feb, In : European Journal of Cancer. 40, 3, p. 422-428 7 p.

    Research output: Contribution to journalArticle

  52. 2005
  53. European multi-centre case-control study on risk factors for rare cancers of unknown aetiology

    Lynge, E., Afonso, N., Kaerlev, L., Olsen, J., Sabroe, S., Ahrens, W., Mikael Eriksson, Guenel, P., Merletti, F., Stengrevics, A., Suarez-Varela, M., Costa-Pererra, A. & Vyberg, M., 2005, In : European Journal of Cancer. 41, 4, p. 601-612

    Research output: Contribution to journalArticle

  54. The Notch pathway in cancer: Differentiation gone awry.

    Jonas Sjölund, Manetopoulos, C., Stockhausen, M. & Håkan Axelson, 2005, In : European Journal of Cancer. 41, p. 2620-2629

    Research output: Contribution to journalReview article

Previous 1 2 3 Next